Skip to content

Clinical trials

Terminated Lung Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Terminated Country / region: Taiwan Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20151
20171
20181
20201
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation2
Pfizer2
Amgen1
AstraZeneca1
Hanmi Pharmaceutical Company Limited1
Novartis Pharmaceuticals1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms9
Carcinoma, Non-Small-Cell Lung8
Neoplasms5
Bronchial Neoplasms3
Carcinoma, Bronchogenic3
Lung Diseases3
Neoplasms by Site3
Respiratory Tract Diseases3
Respiratory Tract Neoplasms3
Thoracic Neoplasms3

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.